Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

• Main Authors: Moreau, P, Joshua, D, Chng, W-J, Palumbo, A, Goldschmidt, H, Hajek, R, Facon, T, Ludwig, H, Pour, L, Niesvizky, R, Oriol, A, Rosinol, L, Suvorov, A, Gaidano, G, Pika, T, Weisel, K, Goranova-Marinova, V, Gillenwater, HH, Mohamed, N, Aggarwal, S, Feng, S, Dimopoulos, MA
• 其他作者: DEAN'S OFFICE (MEDICINE)
• 格式: Article
• 語言: English
• 出版: NATURE PUBLISHING GROUP 2022
• 主題: Science & Technology; Life Sciences & Biomedicine; Oncology; Hematology; STEM-CELL TRANSPLANTATION; LENALIDOMIDE MAINTENANCE; RETREATMENT; INHIBITOR
• 在線閱讀: https://scholarbank.nus.edu.sg/handle/10635/229017

10.1038/leu.2016.186